Nurix Therapeutics Inc Asset Turnover Ratio (NRIX), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nurix Therapeutics Inc   (NASDAQ: NRIX)
 

Nurix Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Nurix Therapeutics Inc asset turnover ratio, the ability of Nurix Therapeutics Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.92 in the third quarter (Aug 31 2026), a new company high.

Within sector 31 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 3176, from total ranking in the second quarter 2026 at 3623.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NRIX Asset Turnover Ratio (Aug 31 2026)
III. Quarter		 (May 31 2026)
II. Quarter		 (Feb 28 2026)
I. Quarter		 (Nov 30 2025)
IV. Quarter		 (Aug 31 2025)
III. Quarter
Y / Y Asset Change 128.78 % -9.47 % 3.43 % 2.81 % 1.82 %
Y / Y Revenue Change 8426.27 % -79.47 % -66.12 % 2.21 % -37.29 %
Asset Turnover Ratio (TTM) 0.92 0.06 0.12 0.14 0.14
NRIX's Total Ranking # 3176 # 3623 # 3149 # 3177 # 3432
Seq. Asset Change 123.19 % -15.81 % -7.56 % 31.71 % -11.68 %
Seq. Revenue Change 7342.93 % 44.64 % -53.95 % 71.99 % -82.08 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 132
Overall Market # 3176

Asset Turnover Ratio Statistics
High Average Low
0.92 0.15 0.05
(Aug 31 2026)   (May 31 2021)




NRIX Company Profile • Back to NRIX Efficiency Comparisons • Compare NRIX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Aug 31 2026 Assets at quarter ending Aug 31 2026
Brightspring Health Services Inc   1.52 $ 9,479.144  Millions$ 6,219.741  Millions
Sonoma Pharmaceuticals Inc   1.50 $ 23.490  Millions$ 15.698  Millions
Medinotec Inc   1.48 $ 10.211  Millions$ 6.890  Millions
Idexx Laboratories Inc  1.34 $ 4,663.675  Millions$ 3,471.425  Millions
Medpace Holdings Inc   1.34 $ 2,838.385  Millions$ 2,116.215  Millions
Exagen Inc   1.34 $ 72.769  Millions$ 54.317  Millions
Edap Tms Sa  1.32 $ 111.370  Millions$ 84.080  Millions
Myomo Inc   1.32 $ 47.775  Millions$ 36.134  Millions
Precipio inc   1.30 $ 27.762  Millions$ 21.289  Millions
Liquidia Corporation  1.29 $ 621.865  Millions$ 483.582  Millions
Tactile Systems Technology Inc   1.28 $ 357.176  Millions$ 279.255  Millions
Hca Healthcare Inc   1.26 $ 78,701.000  Millions$ 62,218.000  Millions
Electromed Inc   1.23 $ 74.561  Millions$ 60.436  Millions
Angiodynamics Inc   1.23 $ 323.784  Millions$ 262.480  Millions
Tela Bio Inc   1.22 $ 79.525  Millions$ 65.135  Millions
Henry Schein Inc   1.21 $ 13,734.000  Millions$ 11,352.500  Millions
Tarsus Pharmaceuticals Inc   1.21 $ 682.203  Millions$ 564.984  Millions
Harvard Bioscience Inc   1.17 $ 90.339  Millions$ 77.399  Millions
Axsome Therapeutics Inc   1.16 $ 865.268  Millions$ 747.908  Millions
Sanuwave Health Inc   1.14 $ 41.031  Millions$ 35.892  Millions
Ironwood Pharmaceuticals inc   1.14 $ 400.296  Millions$ 351.797  Millions
Biodesix Inc   1.13 $ 105.212  Millions$ 92.846  Millions
Indivior Pharmaceuticals Inc   1.11 $ 1,376.000  Millions$ 1,240.750  Millions
Pro dex Inc   1.11 $ 79.578  Millions$ 71.817  Millions
Madrigal Pharmaceuticals Inc   1.11 $ 1,427.940  Millions$ 1,291.488  Millions
Kiniksa Pharmaceuticals International Plc  1.09 $ 945.963  Millions$ 867.066  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.08 $ 28.722  Millions$ 26.550  Millions
Corcept Therapeutics Inc  1.08 $ 963.647  Millions$ 893.565  Millions
Cerus Corporation  1.06 $ 226.798  Millions$ 213.671  Millions
Alphatec Holdings Inc   1.06 $ 839.652  Millions$ 794.614  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.